IGY Life Sciences achieves 94.8% purity of IgY, opening the way for large-scale health applications for Nutraceuticalsigyadmin2022-12-14T02:27:12+00:00September 7th, 2022|Read More
IGY Life Sciences Partners with MMS Holdings to Develop Novel COVID-19 Antibody Treatmentigyadmin2022-12-14T02:27:58+00:00June 8th, 2020|Read More
